References
- Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65. DOI: https://doi.org/10.1517/14740338.2013.827660.
- Santos-Pérez MI, Fierro I, Salgueiro-Vázquez ME, et al. A polypharmacy risk prediction model for elderly patients based on sociodemographic and clinical factors. Int J Clin Pharmacol Ther. 2018;56(12):577–584. DOI: https://doi.org/10.5414/CP203238.
- Kojima T, Akishita M, Nakamura T, et al. Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatr Gerontol Int. 2012;12(3):425–430. DOI: https://doi.org/10.1111/j.1447-0594.2011.00783.x.
- Charlesworth CJ, Smit E, Lee DSH, et al. Polypharmacy among adults aged 65 years and older in the United States: 1988–2010. J Gerontol A Biol Sci Med Sci. 2015;70(8):989–995. Oxford University Press, DOI: https://doi.org/10.1093/gerona/glv013.
- Hovstadius B, Petersson G. Factors leading to excessive polypharmacy. Clin Geriatr Med. 2012;28(2):159–172. DOI: https://doi.org/10.1016/j.cger.2012.01.001.
- Komiya H, Umegaki H, Asai A, et al. Factors associated with polypharmacy in elderly home-care patients. Geriatr Gerontol Int. 2018;18(1):33–41. DOI: https://doi.org/10.1111/ggi.13132.
- Rieckert A, Trampisch US, Klaaßen-Mielke R, et al. Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy. BMC Fam Pract. 2018;19(1):113. DOI: https://doi.org/10.1186/s12875-018-0795-5.
- Ellenbogen MI, Wang P, Overton HN, et al. Frequency and predictors of polypharmacy in US Medicare patients: a cross-sectional analysis at the patient and physician levels. Drugs Aging. 2020;37(1):57–65. DOI: https://doi.org/10.1007/s40266-019-00726-0.
- Halli-Tierney A, Scarbrough C, Carroll D. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019;100:32–38.
- Hicks LA, Bartoces MG, Roberts RM, et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clin Infect Dis. 2015;60(9):1308–1316.
- McDonald DC, Carlson K, Izrael D. Geographic variation in opioid prescribing in the U.S. J Pain. 2012;13(10):988–996. DOI: https://doi.org/10.1016/j.jpain.2012.07.007.
- Maust DT, Lin LA, Blow FC, et al. County and physician variation in benzodiazepine prescribing to Medicare beneficiaries by primary care physicians in the USA. J Gen Intern Med. 2018;33(12):2180–2188. DOI: https://doi.org/10.1007/s11606-018-4670-9.
- Schmittdiel JA, Raebel MA, Dyer W, et al. Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. J Am Pharm Assoc (2003). 2014;54(4):374–382. DOI: https://doi.org/10.1331/JAPhA.2014.13195.
- American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–2246. DOI: https://doi.org/10.1111/jgs.13702.
- Program Guidance & Specifications | CMS [Internet] [cited 2021 Aug 10]. Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/program-guidance-and-specifications
- Alrasheed MM, Alhawassi TM, Alanazi A, et al. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study. Clin Interv Aging. 2018;13:1401–1408. DOI: https://doi.org/10.2147/CIA.S165588.
- Wongrakpanich S, Wongrakpanich A, Melhado K, et al. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9(1):143–150. DOI: https://doi.org/10.14336/AD.2017.0306.
- Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4–S9. DOI: https://doi.org/10.1093/gerona/glu057.
- Ie K, Felton M, Springer S, et al. Physician factors associated with polypharmacy and potentially inappropriate medication use. J Am Board Fam Med. 2017;30(4):528–536. DOI: https://doi.org/10.3122/jabfm.2017.04.170121.
- Nothelle SK, Sharma R, Oakes A, et al. Factors associated with potentially inappropriate medication use in community-dwelling older adults in the United States: a systematic review. Int J Pharm Pract. 2019;27(5):408–423. DOI: https://doi.org/10.1111/ijpp.12541.
- Ramaswamy R, Maio V, Diamond JJ, et al. Potentially inappropriate prescribing in elderly: assessing doctor knowledge, confidence and barriers. J Eval Clin Pract. 2011;17(6):1153–1159. DOI: https://doi.org/10.1111/j.1365-2753.2010.01494.x.
- Gokula M, Holmes HM. Tools to reduce polypharmacy. Clin Geriatr Med. 2012;28(2):323–341. DOI: https://doi.org/10.1016/j.cger.2012.01.011.
- Accetta R. Polypharmacy: strategies for reducing the consequences of multiple medications. Todays Geriatr Med. 2016;9:24.
- Farrell B, Mangin D. Deprescribing is an essential part of good prescribing. Am Fam Physician. 2019;99:7–9.
- Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019;100:32–38.
- Molokhia M, Majeed A. Current and future perspectives on the management of polypharmacy. BMC Fam Pract. 2017;18(1):70. DOI: https://doi.org/10.1186/s12875-017-0642-0.